Kerala Ayurveda Reports Significant Financial Decline, Highlighting Profitability Challenges in March 2025

Kerala Ayurveda, a microcap player in the Pharmaceuticals & Biotechnology sector, has recently reported its financial results for the quarter ending March 2025. The results indicate a notable shift in the company's financial landscape, with a significant adjustment in its evaluation score, which has moved to -18 from -2 over the past three months.
The financial data reveals several concerning trends. The Profit Before Tax less Other Income (PBT) has recorded a substantial decline, standing at Rs -14.54 crore, which reflects a drastic change compared to the average PBT of the previous four quarters. Similarly, the Profit After Tax (PAT) has also shown a marked decrease, reported at Rs -15.54 crore, indicating a challenging environment for profitability.

Additionally, the interest expenses have surged dramatically, suggesting increased borrowings, while the Operating Profit has reached its lowest point in five quarters at Rs -10.14 crore. This has resulted in a deteriorating Operating Profit Margin, now at -32.38%. The Earnings per Share (EPS) has also fallen to Rs -12.92, further highlighting the company's struggles in generating returns for shareholders.

Overall, these financial results underscore a challenging period for Kerala Ayurveda, prompting a revision in its score.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.